AHC
TMO icon

Adell Harriman & Carpenter’s Thermo Fisher Scientific TMO Stock Holding History

Adell Harriman & Carpenter’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.62M Buy
9,398
+216
+2% +$117K 0.28% 66
2025
Q4 		$5.32M Buy
9,182
+554
+6% +$313K 0.32% 58
2025
Q3 		$4.18M Sell
8,628
-590
-6% -$275K 0.25% 69
2025
Q2 		$3.74M Sell
9,218
-3,606
-28% -$1.51M 0.25% 68
2025
Q1 		$6.38M Buy
12,824
+1,012
+9% +$548K 0.48% 50
2024
Q4 		$6.15M Sell
11,812
-1,080
-8% -$594K 0.43% 51
2024
Q3 		$7.97M Buy
12,892
+571
+5% +$338K 0.58% 45
2024
Q2 		$6.81M Buy
12,321
+222
+2% +$127K 0.53% 47
2024
Q1 		$7.03M Sell
12,099
-147
-1% -$82.5K 0.58% 50
2023
Q4 		$6.5M Sell
12,246
-3,011
-20% -$1.46M 0.6% 49
2023
Q3 		$7.72M Sell
15,257
-227
-1% -$121K 0.8% 42
2023
Q2 		$8.04M Sell
15,484
-110
-0.7% -$59.4K 0.82% 42
2023
Q1 		$8.99M Buy
15,594
+757
+5% +$427K 0.97% 32
2022
Q4 		$8.17M Sell
14,837
-688
-4% -$365K 0.94% 38
2022
Q3 		$7.87M Buy
15,525
+360
+2% +$201K 0.96% 36
2022
Q2 		$8.24M Sell
15,165
-179
-1% -$98.5K 1.01% 35
2022
Q1 		$9.06M Buy
15,344
+848
+6% +$487K 0.88% 38
2021
Q4 		$9.67M Buy
14,496
+786
+6% +$491K 0.9% 38
2021
Q3 		$7.83M Buy
13,710
+750
+6% +$412K 0.82% 42
2021
Q2 		$6.54M Buy
12,960
+414
+3% +$195K 0.69% 49
2021
Q1 		$5.73M Buy
12,546
+729
+6% +$348K 0.69% 51
2020
Q4 		$5.5M Sell
11,817
-145
-1% -$68K 0.72% 46
2020
Q3 		$5.28M Buy
11,962
+1,200
+11% +$496K 0.79% 44
2020
Q2 		$3.9M Buy
10,762
+1,250
+13% +$419K 0.67% 50
2020
Q1 		$2.7M Sell
9,512
-3,600
-27% -$1.14M 0.57% 56
2019
Q4 		$4.26M Buy
13,112
+1,605
+14% +$487K 0.7% 50
2019
Q3 		$3.35M Buy
11,507
+25
+0.2% +$7.16K 0.61% 55
2019
Q2 		$3.37M Sell
11,482
-1,060
-8% -$292K 0.63% 52
2019
Q1 		$3.43M Sell
12,542
-25
-0.2% -$6.22K 0.67% 51
2018
Q4 		$2.81M Buy
12,567
+4,205
+50% +$987K 0.62% 52
2018
Q3 		$2.04M Buy
8,362
+2,335
+39% +$537K 0.38% 66
2018
Q2 		$1.25M Buy
6,027
+675
+13% +$143K 0.25% 82
2018
Q1 		$1.1M Buy
5,352
+550
+11% +$115K 0.23% 84
2017
Q4 		$912K Sell
4,802
-112
-2% -$21.5K 0.19% 89
2017
Q3 		$930K Buy
4,914
+450
+10% +$81.5K 0.2% 90
2017
Q2 		$779K Buy
4,464
+600
+16% +$101K 0.18% 91
2017
Q1 		$594K Buy
3,864
+1,300
+51% +$199K 0.14% 96
2016
Q4 		$362K Buy
2,564
+117
+5% +$17.3K 0.09% 105
2016
Q3 		$389K Sell
2,447
-50
-2% -$7.71K 0.1% 100
2016
Q2 		$369K Sell
2,497
-100
-4% -$14.8K 0.1% 104
2016
Q1 		$368K Buy
2,597
+55
+2% +$7.37K 0.1% 106
2015
Q4 		$361K Buy
2,542
+800
+46% +$107K 0.1% 109
2015
Q3 		$213K Hold
1,742
– – 0.06% 133
2015
Q2 		$226K Buy
+1,742
New +$227K 0.06% 134

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Adell Harriman & Carpenter's TMO Position: Q1 2026 in Review

Adell Harriman & Carpenter increased its Thermo Fisher Scientific (TMO) stake by 2.4% in Q1 2026, buying an estimated $117K and bringing the position to 9,398 shares worth $4.62M. The position accounts for 0.28% of the portfolio, ranked #66.

Adell Harriman & Carpenter first reported a position in TMO in Q2 2015 and has held it in 44 quarters since. The position peaked at $9.67M in Q4 2021. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Adell Harriman & Carpenter held 9,398 shares of Thermo Fisher Scientific worth $4.62M as of Q1 2026.
  • Adell Harriman & Carpenter bought 216 Thermo Fisher Scientific shares in Q1 2026, an estimated $117K.
  • Thermo Fisher Scientific made up 0.28% of Adell Harriman & Carpenter's portfolio in Q1 2026, its #66 holding.
  • Adell Harriman & Carpenter first reported a position in Thermo Fisher Scientific in Q2 2015 and has held it in 44 quarters since.
  • Adell Harriman & Carpenter's Thermo Fisher Scientific position peaked at $9.67M in Q4 2021.
  • 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Adell Harriman & Carpenter's 13F filing for Q1 2026, filed 4 May 2026.